Health
HIV ‘wonder drug’ may not be as effective as hoped in sub-Saharan Africa, study suggests – News-Medical.Net
Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day….
Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day. The study finds that this so-called ‘wonder drug’ may be less effective in patients resistant to older drugs.
As HIV copies itself and replicates, it can develop errors, or ‘mutations’, in its genetic code (its RNA). While a drug may initially be able to supress or even kill the virus, certain mutations can allow the virus to develop resistance…
Continue Reading
